Return On Assets of Aptevo Therapeutics Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aptevo Therapeutics Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Aptevo Therapeutics Inc. Return On Assets for the quarter ending 30 Sep 2025 was -159%, a 22% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Return On Assets for 2024 was -153%, a 154% decline from 2023.
  • Aptevo Therapeutics Inc. annual Return On Assets for 2023 was -60%, a 381% decline from 2022.
  • Aptevo Therapeutics Inc. annual Return On Assets for 2022 was 21%.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Aptevo Therapeutics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -159% -28% -22% 01 Jul 2025 30 Sep 2025
Q2 2025 -176% -58% -49% 01 Apr 2025 30 Jun 2025
Q1 2025 -176% -66% -60% 01 Jan 2025 31 Mar 2025
Q4 2024 -153% -92% -154% 01 Oct 2024 31 Dec 2024
Q3 2024 -131% -79% -154% 01 Jul 2024 30 Sep 2024
Q2 2024 -118% -64% -119% 01 Apr 2024 30 Jun 2024
Q1 2024 -110% -163% -307% 01 Jan 2024 31 Mar 2024
Q4 2023 -60% -82% -381% 01 Oct 2023 31 Dec 2023
Q3 2023 -52% -66% -447% 01 Jul 2023 30 Sep 2023
Q2 2023 -54% -68% -491% 01 Apr 2023 30 Jun 2023
Q1 2023 53% +102% 01 Jan 2023 31 Mar 2023
Q4 2022 21% +65% 01 Oct 2022 31 Dec 2022
Q3 2022 15% +60% 01 Jul 2022 30 Sep 2022
Q2 2022 14% +64% 01 Apr 2022 30 Jun 2022
Q1 2022 -49% +14% +22% 01 Jan 2022 31 Mar 2022
Q4 2021 -44% +9.1% +17% 01 Oct 2021 31 Dec 2021
Q3 2021 -45% +11% +19% 01 Jul 2021 30 Sep 2021
Q2 2021 -50% -2% -4.2% 01 Apr 2021 30 Jun 2021
Q1 2021 -63% -13% -26% 01 Jan 2021 31 Mar 2021
Q4 2020 -53% +9.3% +15% 01 Oct 2020 31 Dec 2020
Q3 2020 -56% +11% +17% 01 Jul 2020 30 Sep 2020
Q2 2020 -48% +23% +32% 01 Apr 2020 30 Jun 2020
Q1 2020 -50% +16% +24% 01 Jan 2020 31 Mar 2020
Q4 2019 -62% +1.8% +2.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -67% -16% -32% 01 Jul 2019 30 Sep 2019
Q2 2019 -71% -72% -7109% 01 Apr 2019 30 Jun 2019
Q1 2019 -65% -68% -2421% 01 Jan 2019 31 Mar 2019
Q4 2018 -64% -70% -1090% 01 Oct 2018 31 Dec 2018
Q3 2018 -51% -53% -3013% 01 Jul 2018 30 Sep 2018
Q2 2018 1% +115% 01 Apr 2018 30 Jun 2018
Q1 2018 2.8% +106% 01 Jan 2018 31 Mar 2018
Q4 2017 6.4% +106% 01 Oct 2017 31 Dec 2017
Q3 2017 1.8% +96% 01 Jul 2017 30 Sep 2017
Q2 2017 -114% 01 Apr 2017 30 Jun 2017
Q1 2017 -103% 01 Jan 2017 31 Mar 2017
Q4 2016 -99% 01 Oct 2016 31 Dec 2016
Q3 2016 -94% 01 Jul 2016 30 Sep 2016

Aptevo Therapeutics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -153% -92% -154% 01 Jan 2024 31 Dec 2024
2023 -60% -82% -381% 01 Jan 2023 31 Dec 2023
2022 21% +65% 01 Jan 2022 31 Dec 2022
2021 -44% +9.1% +17% 01 Jan 2021 31 Dec 2021
2020 -53% +9.3% +15% 01 Jan 2020 31 Dec 2020
2019 -62% +1.8% +2.8% 01 Jan 2019 31 Dec 2019
2018 -64% -70% -1090% 01 Jan 2018 31 Dec 2018
2017 6.4% +106% 01 Jan 2017 31 Dec 2017
2016 -99% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.